title: When to initiate anti Pneumocystis carinii prophylaxis in acute lymphoblastic leukemia treatment?
authors.forename: A
authors.initials: A
authors.lastname: Broyart
authors.forename: A
authors.initials: A
authors.lastname: Debard
authors.forename: P
authors.initials: P
authors.lastname: Rohrlich
authors.forename: C
authors.initials: C
authors.lastname: Rahimy
authors.forename: B
authors.initials: B
authors.lastname: Lescoeur
authors.forename: E
authors.initials: E
authors.lastname: Vilmer
mesh_terms: D002675:Child, Preschool; D005260:Female; D006801:Humans; D007108:Immune Tolerance / Q000276:immunology; D008297:Male; D008875:Middle Aged; D011020:Pneumonia, Pneumocystis / Q000517:prevention & control*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000150:complications* / Q000276:immunology / Q000382:microbiology